PMID: 7014327Mar 1, 1981Paper

Peptides and the control of meal size

Diabetologia
S C WoodsD Porte

Abstract

There are now a large number of experiments demonstrating that peripheral administration of exogenous cholecystokinin or its synthetic analogue, CCK-8, reduces meal size in a number of species. The peptide interacts with other factors which influence satiety, and treatments thought to be effective in eliciting secretion of cholecystokinin have predictable effects on meal size. Cholecystokinin is effective in the genetically obese Zucker rat, obese rats with lesions of the ventromedial hypothalamus, and subdiaphragmatically vagotomized rats. Somatostatin and bombesin are also reasonable candidates for satiety factors. Intraperitoneal naloxone reduces meal size in rats, and beta-endorphin injected intraventricularly causes an increase in meal size of 50% over 30 minutes. We conclude that cholecystokinin and bombesin may interact in weight regulation and control of meal time food intake.

References

Jan 1, 1979·Pharmacology, Biochemistry, and Behavior·C L McLaughlin, C A Baile
Nov 8, 1979·Nature·J GibbsS P Maddison
Sep 12, 1979·Biochemical and Biophysical Research Communications·T W Moody, C B Pert
Dec 1, 1979·Pharmacology, Biochemistry, and Behavior·B M KingR D Olson
Dec 1, 1979·Pharmacology, Biochemistry, and Behavior·D M NanceA J Kastin
Dec 1, 1979·Physiology & Behavior·D N LorenzG P Smith
May 19, 1978·Science·C B NemeroffA J Prange
May 7, 1979·Life Sciences·B BrandsC W Gowdey
Dec 1, 1977·Physiology & Behavior·S M AnikaK A Houpt
Oct 1, 1977·Physiology & Behavior·J R Martin, D Novin
Apr 1, 1978·Journal of Comparative and Physiological Psychology·N J Kenney, A N Epstein
Aug 1, 1978·Journal of Comparative and Physiological Psychology·F S KralyG P Smith
Jul 1, 1978·Physiology & Behavior·S Mineka, C T Snowdon
Nov 1, 1978·Behavioral Biology·J A Deutsch, M F Gonzalez
Jan 1, 1976·Annual Review of Medicine·R Guillemin, J E Gerich
Mar 10, 1977·Nature·J A Deutsch, W T Hardy
Jul 1, 1977·Neuropharmacology·L Grandison, A Guidotti
May 1, 1976·Journal of Comparative and Physiological Psychology·J J SternJ Kruper
Sep 1, 1976·Physiology & Behavior·L L BernsteinJ C Zimmerman
May 1, 1975·Life Sciences·S G Holtzman
Sep 1, 1975·Journal of Comparative and Physiological Psychology·J AntinG P Smith
Sep 1, 1973·Journal of Comparative and Physiological Psychology·J GibbsG P Smith
Jan 1, 1974·Psychological Review·S C WoodsJ R Vasselli
Mar 1, 1974·Physiology & Behavior·J HoltG P Smith
Jan 1, 1971·Annual Review of Physiology·B G Hoebel
Jun 1, 1972·Behavioral Biology·H S KoopmansP J Branson
Apr 19, 1969·Nature·Y OomuraM J Wayner
Apr 1, 1969·Journal of Comparative and Physiological Psychology·J D DavisA J Turausky
Jan 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·J R Smith, E J Simon
Mar 1, 1980·Physiology & Behavior·S C Woods, I L Bernstein
Mar 1, 1981·Diabetologia·J HavrankovaJ Roth
Mar 1, 1981·Diabetologia·D Porte, S C Woods
Apr 1, 1980·Pharmacology, Biochemistry, and Behavior·M J PerlowR J Wyatt
Jan 1, 1980·Peptides·C F Martin, J Gibbs
Mar 1, 1980·Physiology & Behavior·V E MendelJ Elashoff
Apr 1, 1980·Physiology & Behavior·K Mueller, S Hsiao
Jul 14, 1980·Life Sciences·M BrownJ Rivier

❮ Previous
Next ❯

Citations

Mar 1, 1981·Diabetologia·D Porte, S C Woods
Oct 1, 1992·Diabetologia·R S Lin, W C Lee
Jan 1, 1991·European Journal of Applied Physiology and Occupational Physiology·A HiraiO Shido
Jul 16, 1982·European Journal of Pharmacology·D LuttingerA J Prange
Oct 5, 1981·Life Sciences·L D McKayS C Woods
Nov 2, 1981·Life Sciences·J E Morley, A S Levine
Oct 4, 1982·Life Sciences·J E Morley, A S Levine
Aug 16, 1982·Life Sciences·P J Kulkosky, J Gibbs
Jul 15, 1985·Life Sciences·J Gibbs
Mar 1, 1982·Physiology & Behavior·P J KulkoskyG P Smith
Jun 1, 1985·Physiology & Behavior·I L TaylorJ Elashoff
Sep 1, 1993·Physiology & Behavior·M M MeguidZ J Yang
Oct 1, 1989·Pharmacology, Biochemistry, and Behavior·P J KulkoskyM A Foderaro
Jan 1, 1982·Neuroscience and Biobehavioral Reviews·K A Houpt
Jan 1, 1985·Neuroscience and Biobehavioral Reviews·P J Kulkosky
Jan 1, 1996·Neuroscience and Biobehavioral Reviews·L L Bernardis, L L Bellinger
Sep 1, 1982·Peptides·L J Stein, S C Woods
Jan 1, 1982·Peptides·J E MorleyB S Handwerger
Jan 1, 1985·Peptides·J E MorleyS E Nizielski
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·J A Thornhill, W S Saunders
Jan 1, 1986·Comparative Biochemistry and Physiology. A, Comparative Physiology·C J Bailey, P R Flatt
Jun 1, 1985·Brain Research Bulletin·D T FullertonI H Carlson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.